184 related articles for article (PubMed ID: 22693581)
1. Conserved expression signatures between medaka and human pigment cell tumors.
Schartl M; Kneitz S; Wilde B; Wagner T; Henkel CV; Spaink HP; Meierjohann S
PLoS One; 2012; 7(5):e37880. PubMed ID: 22693581
[TBL] [Abstract][Full Text] [Related]
2. Expression signatures of early-stage and advanced medaka melanomas.
Klotz B; Kneitz S; Regensburger M; Hahn L; Dannemann M; Kelso J; Nickel B; Lu Y; Boswell W; Postlethwait J; Warren W; Kunz M; Walter RB; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2018 Jun; 208():20-28. PubMed ID: 29162497
[TBL] [Abstract][Full Text] [Related]
3. Whole Body Melanoma Transcriptome Response in Medaka.
Schartl M; Shen Y; Maurus K; Walter R; Tomlinson C; Wilson RK; Postlethwait J; Warren WC
PLoS One; 2015; 10(12):e0143057. PubMed ID: 26714172
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional background effects on a tumor driver gene in different pigment cell types of medaka.
Abdulsahib S; Boswell W; Boswell M; Savage M; Schartl M; Lu Y
J Exp Zool B Mol Dev Evol; 2024 May; 342(3):252-259. PubMed ID: 37877158
[TBL] [Abstract][Full Text] [Related]
6. A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies.
Schartl M; Wilde B; Laisney JA; Taniguchi Y; Takeda S; Meierjohann S
J Invest Dermatol; 2010 Jan; 130(1):249-58. PubMed ID: 19609310
[TBL] [Abstract][Full Text] [Related]
7. Generating and analyzing fish models of melanoma.
Patton EE; Mathers ME; Schartl M
Methods Cell Biol; 2011; 105():339-66. PubMed ID: 21951537
[TBL] [Abstract][Full Text] [Related]
8. Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas.
Klotz B; Kneitz S; Lu Y; Boswell W; Postlethwait J; Warren W; Walter RB; Schartl M
G3 (Bethesda); 2019 Jul; 9(7):2267-2276. PubMed ID: 31101653
[TBL] [Abstract][Full Text] [Related]
9. Application of the Transcriptional Disease Signature (TDSs) to Screen Melanoma-Effective Compounds in a Small Fish Model.
Lu Y; Boswell W; Boswell M; Klotz B; Kneitz S; Regneri J; Savage M; Mendoza C; Postlethwait J; Warren WC; Schartl M; Walter RB
Sci Rep; 2019 Jan; 9(1):530. PubMed ID: 30679619
[TBL] [Abstract][Full Text] [Related]
10. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
[TBL] [Abstract][Full Text] [Related]
11. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
12. Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines.
Venza M; Dell'Aversana C; Visalli M; Altucci L; Teti D; Venza I
Tumori; 2014; 100(1):e4-7. PubMed ID: 24675509
[TBL] [Abstract][Full Text] [Related]
13. Xmrk in medaka: a new genetic melanoma model.
Patton EE; Nairn RS
J Invest Dermatol; 2010 Jan; 130(1):14-7. PubMed ID: 20010863
[TBL] [Abstract][Full Text] [Related]
14. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
15. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
16. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.
Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK
Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165
[TBL] [Abstract][Full Text] [Related]
17. The prognostic potential of alternative transcript isoforms across human tumors.
Trincado JL; Sebestyén E; Pagés A; Eyras E
Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of human uveal melanoma invasion and metastasis.
Seftor EA; Meltzer PS; Kirschmann DA; Pe'er J; Maniotis AJ; Trent JM; Folberg R; Hendrix MJ
Clin Exp Metastasis; 2002; 19(3):233-46. PubMed ID: 12067204
[TBL] [Abstract][Full Text] [Related]
19. Uveal vs. cutaneous melanoma. Origins and causes of the differences.
Belmar-Lopez C; Mancheno-Corvo P; Saornil MA; Baril P; Vassaux G; Quintanilla M; Martin-Duque P
Clin Transl Oncol; 2008 Mar; 10(3):137-42. PubMed ID: 18321815
[TBL] [Abstract][Full Text] [Related]
20. Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.
Onken MD; Ehlers JP; Worley LA; Makita J; Yokota Y; Harbour JW
Cancer Res; 2006 May; 66(9):4602-9. PubMed ID: 16651410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
